I

iTeos Therapeutics
D

ITOS

7.40500
USD
-0.07
(-0.94%)
مغلق
حجم التداول
16,936
الربح لكل سهم
-6
العائد الربحي
-
P/E
-2
حجم السوق
270,533,663
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: iTeos Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.